Oblique Therapeutics
Biotechnology, Health Care, Hospital, Medical, Pharmaceutical
Founded in 2015-01-01
Göteborg, Vastra Gotaland, Sweden
For Profit
About Oblique Therapeutics
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer. Oblique Therapeutics is an early stage innovation-driven pharmaceutical company aiming at developing transformative medicines against advanced and metastatic cancer.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 2500000 USD
- Last Funding: 2500000 USD (Venture - Series Unknown)
- Funding Status:
Technology Stack
Oblique Therapeutics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Hospital, Medical, Pharmaceutical
Headquarters: Göteborg, Vastra Gotaland, Sweden